Didi Kuo and Co-author Andrew S. Kelly Awarded 2023 Leonard S. Robins Award for Best Paper on Health Politics and Policy
Please join us in congratulating Didi Kuo, Center Fellow at the Freeman Spogli Institute for International Studies (FS), and co-author Andrew S. Kelly, Assistant Professor in the Department of Health Sciences at California State University, East Bay, on being awarded the 2023 Leonard S. Robins Award for the Best Paper on Health Politics and Policy by the American Political Science Association (APSA)!
The Robins Award is named in honor of Leonard S. Robins, who, through his presence and gentle questioning at virtually every health politics panel, graciously nurtured the scholarship of both junior and senior scholars. The award recognizes the best paper on any subject that fits under the rubric of Health Politics and Policy presented at the previous annual APSA meeting.
Kuo and Kelly's award-winning paper, "State Capacity and Public Health: California and COVID-19," investigates the comparative COVID-19 policy response across counties and regions within California. In the description of the 2022 APSA panel "The Politics of Pandemic Response and the Opportunities for Health Policy Reform," during which they presented their paper, it notes that "In moving beyond a consideration of formal state and public health capacity, Kuo and Kelly argue that the more robust policy response of the Bay Area was, in part, a product of partnerships between state and community-based actors. Drawing on the concept of 'embedded autonomy,' Kuo and Kelly reconceptualize public health capacity and consider it within broader issues of state capacity and democracy."
An abstract of the paper can be found below:
On March 17, 2020, six counties in the Bay Area jointly issued the nation’s first shelter-in-place orders in response to the COVID-19 crisis. Cities and states across the United States quickly followed suit, with varying degrees of success. Public health officials have been critical in setting policies, enforcing behavioral and non-pharmaceutical interventions, and communicating with the public. This paper explores the determinants of public health capacity, distinguishing between formal institutional capacity (ie budget, staff) and informal embedded capacity (ie community ties, insulation from political pressures). It argues that informal embedded capacity is critical to public health capacity, but difficult to measure empirically. It concludes by relating public health capacity to broader issues of state capacity and democracy.
Read More
The award recognizes Kuo and Kelly's paper, “State Capacity and Public Health: California and COVID-19,” as the best paper on health politics and policy presented at the 2022 American Political Science Association (APSA) conference.
Stanford Health Policy Seminar: Anna Grummon
Anna H. Grummon is an assistant professor in the Department of Pediatrics at the Stanford School of Medicine. She is a behavioral scientist whose work seeks to identify and evaluate policies that encourage healthy eating and help us live long, healthy lives. In her work, Grummon uses randomized trials, quasi-experiments, and simulation modeling to examine how food policies like warning labels, beverage taxes, and food assistance programs affect what we eat and how healthy we are. She also studies strategies for encouraging people to choose foods that are more environmentally sustainable. Grummon holds a PhD and MSPH in Health Behavior from the University of North Carolina Chapel Hill and a BA with Honors in Human Biology from Stanford. She completed her postdoctoral training at Harvard.
Talk Title: Improving Diet Through Food Policy
Abstract: Unhealthy diet is a leading cause of death in the US. Policy changes could improve diet and help prevent the 500,000 deaths attributable to unhealthy diet in the US each year. This talk will provide evidence about the potential for three policies to improve diet: warning labels for sugary drinks, mandatory calorie disclosures on restaurant menus, and minimum price laws for sugary drinks. Using data from randomized controlled trials, quasi-experiments, and simulation models, we examine how these policies are likely to affect consumer behavior, the food supply, and population health outcomes like obesity.
After registering, you will receive a confirmation email containing information about joining the meeting.
Hybrid Seminar: Lunch will be provided for on-campus participants.
Please register if you plan to attend, both for in-person and via Zoom.
Log in on your computer, or join us in person:
Encina Commons, Room 119
615 Crothers Way
Stanford, CA 94305
How South Korea Can Become a Global Pioneer in Productivity of Health Spending
Do increases in medical spending improve health outcomes? To answer this question, analysts need to quantify the net value of medical spending and measure the productivity of medical care with the output of improvement in survival and quality of life, thereby deducing for what medical conditions the “bang for the buck” is greatest and for what conditions spending outstrips gains in health improvement.
This condition-specific, quality-adjusted net value approach to health spending is known as a “satellite account for health” because it “orbits around” the national income and product accounts that include aggregate health spending to provide a clearer picture of productivity in the health sector. Thus far, researchers have applied this account to the U.S. health sector only, but it would be highly beneficial for many economies. One notable beneficiary would be South Korea, one of the most rapidly aging societies globally. Now new research by Karen Eggleston, the director of APARC’s Asia Health Policy Program, studies the link between medical spending and health outcomes in South Korea, providing evidence on the productivity of medical spending over recent decades.
The research, published by the East-West Center, develops an estimate of the net value of Korean medical spending, which has outpaced most other countries in recent decades. To generate this estimate, Eggleston compares the gains in life expectancy at birth to the increases in medical spending for 2000–2019. Data comes from Korean lifetables and medical expenditures per capita, available from the Korean Statistical Information Services.
Sign up for APARC newsletters to receive our scholars' research updates >
Eggleston shows that, even with the most conservative assumptions ($50,000 per life-year and only 10 percent of health gains due to medical care), the net value of Korean medical spending is positive and substantial. Korean life expectancy at birth increased from 76 in 2000 to 83.3 in 2019, while lifetime medical spending increased by over $19,000. The value of 7.3 additional years of life far outweighs even this rapid increase in spending, implying substantial productivity growth in Korea’s health sector.
Moreover, evidence on condition-specific spending changes and health improvements suggests that Korea’s rapid spending increases yield significant net value. Eggleston’s research indicates that improvements in survival for key conditions afflicting Koreans, such as stroke and cancer, point to productivity gains. “Korea could be a pioneer in developing a national health account that accurately measures net value by medical condition,” she writes.
Condition-specific metrics of health gain per won spent on treatment can help to guide the allocation of investments to promote longer, healthier lives. In the future, analysts could also link condition-specific improvements in survival and morbidity to earnings. Such linkage would particularly benefit South Korea, where focusing on the productivity of older adult employment is crucial given its high labor force participation and relatively low income of older Koreans.
Eggleston advocates for the Korean government to develop a national satellite account for health that can provide valuable evidence for prioritizing investments to address the country’s most pressing health challenges so that productivity improvement will contribute to longer, healthier lives. “By linking National Health Insurance and health outcome data, Korea could develop an accurate measure of medical productivity and a more accurate measure of overall economic productivity, while pioneering development of ‘health satellite accounts’ for overall populations,” Eggleston argues.
Read More
Research by Stanford health economist Karen Eggleston, the director of APARC's Asia Health Policy Program, offers evidence on the link between medical spending and health outcomes in South Korea, showing how the country can benefit from developing a “satellite account for health” to promote high-value innovations for longer, healthier lives.
Incentivizing Quality of Care: New Study Shows Positive Outcomes in Taiwan’s Pay-for-Performance Diabetes Care Program
As healthcare costs for patients with non-communicable diseases such as diabetes have risen, governments and healthcare providers have sought creative measures to align financial incentives with better patient outcomes. One incentive payment system known as “pay-for-performance” (P4P), in which providers are beholden to metric-driven outcomes, represents a potential path forward for healthcare providers to improve healthcare processes, resulting in higher quality and better patient health outcomes. The evidence on the effectiveness of P4P programs, however, is mixed.
To address this uncertainty, a new study, published in The European Journal of Healthcare Economics, assesses the effectiveness, in monetary terms, of a P4P program for patients with diabetes at a hospital system in Taiwan.
The study coauthors, including APARC’s Asia Health Policy Program Director and FSI Senior Fellow Karen Eggleston, employed new patient-level data on clinical indicators, utilization, and expenditures, combined with data from the national death registry, to better understand the costs and benefits of the P4P program. Their results show that Taiwan’s implementation of the P4P program for diabetic care yielded positive results in terms of net value, defined as the value of life years gained minus the cost of care.
Sign up for APARC newsletters to receive our experts' research updates.
Assessing Net Value of Taiwan’s P4P
Taiwan’s Bureau of National Health Insurance (now National Health Insurance Administration) introduced P4P in 2001 and enhanced the program in 2006 with an incentive for pay-for-reporting of outcomes. Financial incentives were used to encourage continuity of care with metrics such as new patient enrollment, follow-up visits, and annual reports, each tied to a specific monetary value. The program’s features are common across P4P, so the study’s findings have implications in other settings that incorporate similar designs in their P4P programs.
The study compares two different groups of patients at a large regional hospital in Taiwan, one consisting of newly enrolled P4P patients and another using P4P patients who have been enrolled since the beginning of the program. The researchers leverage detailed clinical data not used in previous assessments of the P4P program to better identify both costs and longer-term clinical outcomes based on measured biomarkers and predicted mortality.
Using an economic cost-benefit analysis conducted from a budgetary perspective, the study is the first analysis of any P4P program that estimates changes in the quality-adjusted price index relative to usual care. The authors consider health benefits in terms of survival and predicted survival and convert them into monetary terms. This net value approach is especially useful for policymakers and healthcare administrators who implement value-based purchasing and monitor outcomes for any service delivery innovation over time.
The study finds that Taiwan’s P4P program provided a positive net value for payers and patients, ranging from $40,084 USD to $348,717 USD. These positive net value results are primarily derived from health outcomes as measured by lower mortality rates in the P4P versus non-P4P cohorts, across both newly enrolled and continuously enrolled groups of patients. According to the authors, “these encouraging findings of the positive value of quality improvement net of expenditures adds evidence to the literature that has found mixed results of P4P programs.”
This study develops a new model for assessing the net value of service delivery innovations like P4P programs that can be applied in other contexts globally, providing healthcare systems researchers with new tools to better understand an emergent option for incentivized care. With a more economically-translatable understanding of P4P programs, this research helps build the bridge between the oft-disparate worlds of healthcare and policy.
Learn More About the Study
Read More
In the first study to evaluate pay-for-performance implementation at a hospital system in Taiwan, APARC’s Asia Health Policy Program Director Karen Eggleston and co-authors reveal how incentive-based measures to ensure continuity and quality of care resulted in positive health outcomes.
APARC Invites Fall 2023 Asia Studies Fellowship Applications
The Walter H. Shorenstein Asia-Pacific Research Center (APARC) is pleased to invite applications for a suite of fellowships in contemporary Asia studies to begin fall quarter 2023.
The Center offers postdoctoral fellowships that promote multidisciplinary research on contemporary Japan and contemporary Asia broadly defined, inaugural postdoctoral fellowships and visiting scholar positions as part of the newly launched Stanford Next Asia Policy Lab, and a fellowship for experts on Southeast Asia. Learn more about each opportunity and its eligibility and specific application requirements:
Postdoctoral Fellowship on Contemporary Japan
Hosted by the Japan Program at APARC, the fellowship supports research on contemporary Japan in a broad range of disciplines including political science, economics, sociology, law, policy studies, and international relations. Appointments are for one year beginning in fall quarter 2023. The application deadline is December 1, 2022.
Shorenstein Postdoctoral Fellowship on Contemporary Asia
APARC offers two postdoctoral fellowship positions to junior scholars for research and writing on contemporary Asia. The primary research areas focus on political, economic, or social change in the Asia-Pacific region (including Northeast, Southeast, and South Asia), or international relations and international political economy in the region. Appointments are for one year beginning in fall quarter 2023. The application deadline is December 1, 2022.
Next Asia Postdoctoral and Visiting Fellowships
The Stanford Next Asia Policy Lab (SNAPL) is a new innovative policy lab housed at Shorenstein APARC under the directorship of Professor Gi-Wook Shin. The lab is committed to addressing Asia's emergent social, cultural, economic, and political challenges. The Lab's initial research focuses on two themes. The Talent Flows and Development research theme will examine how various forms of talent mobility and strategy have contributed to the developmental success of different nations in the Asia-Pacific region. The Nationalism and Racism theme will explore how nationalism and racism are intertwined to create various forms of exclusion and intolerance across the region.
SNAPL is offering two inaugural postdoctoral fellowships (two years in length) to begin fall quarter 2023. One fellowship will focus on “Talent Flows and Development,” and the other will focus on “Nationalism and Racism” in Asia. The deadline to apply for fall quarter admission is December 1, 2022. SNAPL is also offering two visiting fellow positions to researchers and professionals from Asia with a PhD or a substantial record of achievement related to the Lab's two research themes. These visiting scholar appointments are for one year, and the deadline to apply for fall quarter 2023 admission is March 1, 2023.
Lee Kong Chian NUS-Stanford Fellowship on Southeast Asia
The Lee Kong Chian National University of Singapore-Stanford (LKC NUS-Stanford) Fellowship on Southeast Asia provides an expert on Southeast Asia the opportunity to conduct research on or related to contemporary Southeast Asia. Fellows spend three to four months at Stanford and two to four months at NUS. At Stanford, APARC's Southeast Asia Program hosts the fellowship. Appointments will begin and end within the period from September 1, 2023 to May 31, 2024. The application deadline is January 27, 2023.
Read More
The Center offers a suite of fellowships for Asia researchers to begin fall quarter 2023. These include postdoctoral fellowships on contemporary Japan and the Asia-Pacific region, inaugural postdoctoral fellowships and visiting scholar positions with the newly launched Stanford Next Asia Policy Lab, and fellowships for experts on Southeast Asia.
Department of Health Policy Symposium: Advancing Health Equity
***
Stanford Medicine's new Department of Health Policy held its inaugural departmental symposium on October 6, convening thought leaders and experts in medicine, law, economics and data science. Speakers discussed innovative policy work and scalable solutions for improving health equity. Panelists addressed how to reduce persistent health disparities from three angles: social determinants of health, technology and innovation, and access and affordability.
Discover the powerful role health policy can serve in ensuring the health of all people, not just a privileged few.
***
Keynote Speaker: Kirsten Bibbins-Domingo, PhD, MD
Talk Title: Building Equity in the Research Enterprise
Editor in Chief, Journal of the American Medical Association (JAMA) and JAMA Network Professor of Epidemiology & Biostatistics and Medicine, University of California, San Francisco
Opening Remarks by Stanford Medicine Dean Lloyd Minor
Terrance Mayes, Associate Dean for Equity and Strategic Initiatives
Panel 1 — Social Policy: Strategies for Addressing Structural Determinants of Health
Moderator
Alyce Adams, Stanford Medicine Innovation Professor, Professor of Epidemiology and Population Health, Professor of Health Policy
Panelists
Jeremy Goldhaber-Fiebert, Professor of Health Policy
Gilbert Gonzales, Assistant Professor at the Center for Medicine, Health & Society at Vanderbilt University
Adrienne Sabety, Assistant Professor of Health Policy
***
Panel 2 — Technology: Optimizing Innovation for Health Impact and Equity
Moderator: Josh Salomon, Professor of Health Policy, Director of the Prevention Policy Modeling Lab
Panelists
Joshua Makower, Boston Scientific Applied Biomedical Engineering Professor, Director of the Stanford Byers Center for Biodesign
Grant Miller, Henry J. Kaiser, Jr. Professor, Professor of Health Policy
Sherri Rose, Associate Professor of Health Policy, Co-Director of the Health Policy Data Science Lab
***
Panel 3 — Access & Affordability: How to Finance and Deliver Health Care Innovations Equitably
Moderator: Michelle Mello, Professor of Health Policy, Professor of Law
Panelists
Nicole Dickelson Cooper, Senior Vice President at UnitedHealth Group
Stacie Dusetzina, Associate Professor of Health Policy at Vanderbilt University Medical Center
Maria Polyakova, Assistant Professor of Health Policy
Vindell Washington, Chief Clinical Officer of Verily Health Platforms and CEO of Onduo
#StanfordHealthEquity
WATCH ENTIRE EVENT HERE
Learn More about Stanford Health Policy
Our People, Our Reserch and Our Mission to Improve Health
Advancing Health Equity Slideshow by Beth Duff-Brown
Accreditation
This activity expired on November 20, 2025. Participation records may still be available, but CME/CE credit can no longer be claimed, and certificates are no longer issued for this activity.
***
McCaw Hall, Arrillaga Alumni Center
Protecting Reproductive Health Information after Fall of Roe v. Wade
The Supreme Court ruling eliminating the constitutional right to an abortion could also result in women’s personal reproductive health data being used against them, warns Stanford Health Policy’s Michelle Mello.
The Dobbs v. Jackson Women’s Health Organization ruling could, for example, lead to a woman’s health data in clinician emails, electronic medical records, and online period-tracking platforms being used to incriminate her or her health-care providers, Mello said.
“Ultimately, broader information privacy laws are needed to fully protect patients and clinicians and facilities providing abortion services,” writes Mello, a professor of health policy and law in this JAMA Health Forum article with colleague Kayte Spector-Bagdady, a bioethicist from the University of Michigan. “As states splinter on abortion rights after the Dobbs Supreme Court decision, the stakes for providing robust federal protection for reproductive health information have never been higher.”
Eight states banned abortions on the same day the Dobbs ruling came down, and 13 states that had “trigger bans” that, if Roe v. Wade were struck down, would automatically prohibit abortion within 30 days. Other states are considering reactivating pre-Roe abortion bans and legislators in some states intend to introduce new legislation to curb or ban the medical procedure.”
Three Potential Scenarios
The authors note these new abortion restrictions may clash with privacy protections for health information, laying out three scenarios that could impact millions of women. And, they note, “despite popular misconceptions about the breadth of the Privacy Rule of the Health Information Portability and Accountability Act (HIPAA) and other information privacy laws, current federal law provides little protection against these scenarios.”
The first scenario is that a patient’s private health information may be sought in connection with a law-enforcement proceeding or civil lawsuit for obtaining an illegal abortion. HIPAA privacy regulations and Fourth Amendment rights against unreasonable searches and seizures won’t help physicians and hospitals resist such investigative demands, the authors write. And though physician-patient communications are ordinarily considered privileged information, the scope of that privilege varies greatly from state to state. “In many cases medical record information has been successfully used to substantiate a criminal charge,” the authors write.
The second privacy concern is the potential use of health-care facility records to incriminate an institution or its clinicians for providing abortion services. Relevant records could include electronic health records, employee emails or paging information and mandatory reports to state agencies. Clinicians may not realize that if they are using an institutional email address or server, their institution likely has direct access to information and communications stored there, which can be used to search for violations. State Freedom of Information Act (FOIA) laws also allow citizens to request public records from employees of government hospitals and clinics.
“Additionally, state mandatory reporting laws for child abuse might be interpreted to cover abortions — particularly if life is defined as beginning at fertilization,” the authors note.
The third scenario is that information generated from a woman’s online activity could be used to show she sought an abortion or helped someone to do so. Many women use websites and apps that are not HIPAA-regulated or protected by patient-physician privilege, such as period-tracking apps used by millions of women that collect information on the timing of menstruation and sexual activity.
“There are many instances of internet service providers sharing user data with law enforcement, and prosecutors obtaining and using cellphone data in criminal prosecutions,” write Mello and Spector-Bagdady, adding commercially collected data are also frequently sold to or shared with third parties.
“Thus, pregnant persons may unwittingly create incriminating documentation that has scant legal protection and is useful for enforcing abortion restrictions,” they said.
The immediate problem, Mello notes, is in the states that have already banned abortion or passed restrictive laws.
“There could be a problem with states trying to reach outside their borders to prosecute people, but that could well be unconstitutional,” Mello said.
Some states’ laws sweep abortion pills into the definition of illegal abortions, she said, and there are legal obstacles to supplying the pills across state lines.
“There is a lot of energy going into figuring out a workaround right now, but it’s too soon to call,” Mello said.
Recommended Protections
So how can clinicians and health-care facilities protect their patients and themselves?
When counseling patients of childbearing age about reproductive health issues, clinicians should caution their patients about putting too much medical data online and refer them to expert organizations that will help them minimize their digital footprint.
When documenting reproductive health encounters, the authors said, clinicians should ask themselves: “What information needs to be in the medical record to assure safe, good-quality care, buttress our claim for reimbursement, or comply with clear legal directives?” For example, does information about why a patient may have experienced a miscarriage need to be recorded?
Patients and clinicians should be aware that email and texting may be seen by others, so conversations among staff about reproductive health issues may best be conducted by phone or in person.
Finally, if abortion-related patient information is sought by state law enforcement officials, a facility’s attorney should be consulted about asserting physician-patient privilege and determining whether the disclosure is mandated by law.
Michelle Mello
Read More
Michelle Mello writes that the overturning of Roe v. Wade — ending federal protection over a woman's right to an abortion — could also expose her personal health data in court.
Japanese Population Projected to Live Longer Without Dementia
This press release was originally published by the University of Tokyo. It discusses a new study, published by Lancet Public Health and co-authored by researchers from the University of Tokyo along with FSI Senior Fellow Karen Eggleston, director of the Asia Health Policy Program at APARC, and Jay Bhattacharya, Professor of Health Policy and director of the Center for Demography and Economics of Health and Aging at Stanford.
A new detailed microsimulation, using a database of 40 million people, has examined the future of Japan’s aging population up to 2043. It projects that more people will live longer, and that overall years spent living with dementia will decrease. However, the model highlighted the diversity of impacts on different segments of the population, as Japanese women with a less than high school education aged 75 and over may be disproportionately affected by both dementia and frailty. Better understanding where health gaps like this exist can help inform public health planning, to minimize future economic costs and support those most in need.
Taking care of the older members of society is a common concern around the world. Japan is famous for its long-lived residents, the number of which continues to rise. In 2020, almost 30% of the Japanese population was aged 65 years or older, and this age group is not projected to peak until 2034. Caring for people with age-related ailments, such as dementia and frailty, poses a challenge both to individuals and public health care systems.
Microsimulation models, which are computer models that can provide detailed analysis on an individual basis, are currently used to project future population health in some countries, such as the U.K. and the U.S. Professor Hideki Hashimoto and researchers at the University of Tokyo, along with researchers from Stanford University in the U.S., wanted to create a new microsimulation model for Japan, which would take into account more diverse conditions than had been considered before.
“We developed a new Japanese microsimulation model that accounts for 13 chronic conditions (including heart disease, stroke, diabetes, depression and dependency), as well as frailty and dementia,” explained Hashimoto. “Using an ultralarge data system, we were able to ‘follow’ a virtual cohort of more than 40 million people aged 60 and over from 2016 to 2043.”
According to Hashimoto, projections of aging in Japan usually rely on the “average” status of older people and so don’t consider the diversity of the population. “I believe that problems of aging are a matter of health gaps over the course of people’s lives,” he said. “Our projection brings attention to a widening health gap among older people. It highlighted that women with a less than high school education aged 75 or over are more likely to be affected.”
Identifying where health gaps like this exist could be used to better inform public policy, not only about health care but other influential aspects of life. “Japan’s case may suggest that improvement in educational attainment, as well as population health, could be a key to making a healthier and more manageable aging society,” said Hashimoto.
Positively, this study shows hope for a future where many people live longer and more healthy lives. “People might believe that an increase in cases of dementia is inescapable, given population aging. However, in this study we found that in Japan, despite an aging population, the number of people with dementia is expected to decrease over the next two decades,” said Hashimoto. “Population aging does not necessarily mean an increase of social burden for care, but it does bring a diversity of problems that requires careful study and science-based policy attention, to close the health gap.”
Learn More about the study
Karen Eggleston
Read More
A new microsimulation projects that over the next 20 years, Japanese people will live longer without dementia, but older women with a less than high school education will benefit less than men.
Health Equity Lecture Series — No Equity Without Sovereignty: Intersections of Indigenous Health and Data
You are invited to a Zoom meeting.
After registering, you will receive a confirmation email containing information about joining the meeting.